CoChat

Top or Middle? Up or Down? Toward a Standard Lexicon for Protein Top-Down and Allied Mass Spectrometry Approaches

Open access
Lermyte, Frederik, Tsybin, Yury O., O’Connor, Peter B., Loo, Joseph A. · 2019 · Journal of the American Society for Mass Spectrometry

The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.

Abstract

In recent years, there has been increasing interest in top-down mass spectrometry (TDMS) approaches for protein analysis, driven both by technological advancements and efforts such as those by the multinational Consortium for Top-Down Proteomics (CTDP). Today, diverse sample preparation and ionization methods are employed to facilitate TDMS analysis of denatured and native proteins and their complexes. The goals of these studies vary, ranging from protein and proteoform identification, to determination of the binding site of a (non)covalently-bound ligand, and in some cases even with the aim to study the higher order structure of proteins and complexes. Currently, however, no widely accepted terminology exists to precisely and unambiguously distinguish between the different types of TDMS experiments that can be performed. Instead, ad hoc developed terminology is often used, which potentially complicates communication of top-down and allied methods and their results. In this communication, we consider the different types of top-down (or top-down-related) MS experiments that have been performed and reported, and define distinct categories based on the protocol used and type(s) of information that can be obtained. We also consider the different possible conventions for distinguishing between middle- and top-down MS, based on both sample preparation and precursor ion mass. We believe that the proposed framework presented here will prove helpful for researchers to communicate about TDMS and will be an important step toward harmonizing and standardizing this growing field. Graphical Abstract.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s13361-019-02201-x

Cites

77 of 77 references verified0 citation errors · 0 not checkable

Statistics

Figures

Graphical Abstract
Graphical AbstractCC BY · PubMed Central
Figure 1 Various (non-)native top-down and allied methods as defined in this work
Figure 1 Various (non-)native top-down and allied methods as defined in this workCC BY · PubMed Central
Figure 2 How the methods described in Figure 1 relate to one another, as well as to (extended) bottom-up approaches. The “true” top-down methods are given in bolded text
Figure 2 How the methods described in Figure 1 relate to one another, as well as to (extended) bottom-up approaches. The “true” top-down methods are given in bolded textCC BY · PubMed Central
Figure 3 (Center) general structure of a monoclonal antibody (IgG1), surrounded by simulated (using Bruker DataAnalysis 4.1) isotope distributions for (top-left) the 49 kDa heavy chain, (top-right) the 23 kDa light chain, (bottom-left) an example 1.9 kDa enzymatically derived peptide consisting of the first 18 N-terminal light chain amino acid residues, and (bottom-right) an example 4.4 kDa enzymatically derived peptide consisting of the first 39 light chain N-terminal residues. The former two represent typical precursor masses for middle-up (MU) and middle-down (MD) MS, whereas the latter two fall within the bottom-up (BU) and extended bottom-up (eBU) mass range, respectively. Isotope distributions were simulated using the sequence of adalimumab, and the monoisotopic peak for each species (too low in intensity to be detectable for the heavy and light chain) is indicated in blue. The isotopic envelope is outlined using a solid red line, simulating the signal obtained at a resolution insufficient to resolve the individual isotope peaks
Figure 3 (Center) general structure of a monoclonal antibody (IgG1), surrounded by simulated (using Bruker DataAnalysis 4.1) isotope distributions for (top-left) the 49 kDa heavy chain, (top-right) the 23 kDa light chain, (bottom-left) an example 1.9 kDa enzymatically derived peptide consisting of the first 18 N-terminal light chain amino acid residues, and (bottom-right) an example 4.4 kDa enzymatically derived peptide consisting of the first 39 light chain N-terminal residues. The former two represent typical precursor masses for middle-up (MU) and middle-down (MD) MS, whereas the latter two fall within the bottom-up (BU) and extended bottom-up (eBU) mass range, respectively. Isotope distributions were simulated using the sequence of adalimumab, and the monoisotopic peak for each species (too low in intensity to be detectable for the heavy and light chain) is indicated in blue. The isotopic envelope is outlined using a solid red line, simulating the signal obtained at a resolution insufficient to resolve the individual isotope peaksCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 77 references

Research works printed but not linked: 1

  1. 10.1002/1615-9861(200108)1:8<927::AID-PROT927>3.0.CO;2-T · doi:10.1002/1615-9861(200108)1:8<927::aid-prot927>3.0.co;2-t

Cited by

See all 132

Metadata

Authors
Lermyte, F., Tsybin, Y. O., O’Connor, P. B., & Loo, J. A.
Affiliations
  • University of Warwick (GB)
  • Spectroswiss (Switzerland) (CH)
  • University of California, Los Angeles (US)
Corresponding author
Lermyte, Frederik
Venue
Journal of the American Society for Mass Spectrometry
Published
2019-05-09
Volume
30
Issue
7
Pages
1149-1157
ISSN
1044-0305 (ISSN-L)
OpenAlex
W2944518634
Cited by
132
References
76
Citations by year
2026: 10 · 2025: 14 · 2024: 12 · 2023: 22 · 2022: 18 · 2021: 24 · 2020: 19 · 2019: 13
FWCI
7.35
Type
journal article
Language
en
Open access
Licence
  • cc-by
  • creativecommons.org/licenses/by/4.0 (tdm)
Locations
  • Journal of the American Society for Mass Spectrometry (publishedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Warwick Research Archive Portal (University of Warwick) (submittedVersion)
Funders
  • Engineering and Physical Sciences Research Council (EP/N033191/1)
  • National Institutes of Health (R01GM103479)
Topics
  • Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
  • Physical Sciences › Chemistry › Spectroscopy › Mass Spectrometry Techniques and Applications
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
Keywords
top-down mass spectrometry, middle-down mass spectrometry, standard terminology, protein analysis, proteoforms, protein complexes, sample preparation, ionization methods, protein higher-order structure, ligand binding sites
MeSH terms
Amino Acid Sequence, Animals, Binding Sites, Humans, Models, Molecular, Protein Denaturation, Proteins, Mass Spectrometry, Proteomics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Top or Middle? Up or Down? Toward a Standard Lexicon for Protein Top-Down and Allied Mass Spectrometry Approaches. https://app.cochat.ai/papers/10.1007/s13361-019-02201-x
The paper
Lermyte, F., Tsybin, Y. O., O’Connor, P. B., & Loo, J. A. (2019). Top or Middle? Up or Down? Toward a Standard Lexicon for Protein Top-Down and Allied Mass Spectrometry Approaches. Journal of the American Society for Mass Spectrometry. https://doi.org/10.1007/s13361-019-02201-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.